Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma
Clinical trial NCT01881789 · TERMINATED
Trial details
- NCT number
- NCT01881789
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-28
- Primary completion
- 2019-09-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.